UBS Group’s Centogene N.V. Common Shares CNTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,109
Closed -$1.33K 10248
2023
Q4
$1.33K Buy
+1,109
New +$1.3K ﹤0.01% 8335
2023
Q1
Sell
-827
Closed -$769 10749
2022
Q4
$769 Buy
+827
New +$752 ﹤0.01% 10077
2022
Q3
Sell
-138
Closed 11156
2022
Q2
$0 Buy
+138
New +$433 ﹤0.01% 11166
2021
Q4
Sell
-67
Closed -$1K 10875
2021
Q3
$1K Sell
67
-142
-68% -$1.54K ﹤0.01% 9285
2021
Q2
$2K Sell
209
-1,624
-89% -$17.1K ﹤0.01% 9002
2021
Q1
$22K Buy
1,833
+305
+20% +$3.64K ﹤0.01% 7303
2020
Q4
$16K Buy
1,528
+1,244
+438% +$14.2K ﹤0.01% 7123
2020
Q3
$3K Sell
284
-1,076
-79% -$13.7K ﹤0.01% 7578
2020
Q2
$31K Sell
1,360
-559
-29% -$10.5K ﹤0.01% 6253
2020
Q1
$38K Sell
1,919
-1,817
-49% -$25.2K ﹤0.01% 6049
2019
Q4
$38K Buy
+3,736
New +$44.5K ﹤0.01% 6521

Other funds holding CNTG

UBS Group's CNTG Position: Q1 2024 in Review

UBS Group sold out of Centogene N.V. Common Shares (CNTG) in Q1 2024, closing a stake of 1,109 shares — an estimated $1.33K sold.

UBS Group first reported a position in CNTG in Q4 2019 and held it in 11 quarters. The position peaked at $38K in Q1 2020. 15 funds tracked by Wall St. Rank hold CNTG as of Q1 2024.

  • UBS Group reported no remaining Centogene N.V. Common Shares position as of Q1 2024 after selling out during the quarter.
  • UBS Group sold 1,109 Centogene N.V. Common Shares shares in Q1 2024, an estimated $1.33K.
  • UBS Group first reported a position in Centogene N.V. Common Shares in Q4 2019 and held it in 11 quarters.
  • UBS Group's Centogene N.V. Common Shares position peaked at $38K in Q1 2020.
  • 15 funds tracked by Wall St. Rank held Centogene N.V. Common Shares as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.